Establishment Labs Holdings Inc. Common Shares (ESTA)
Stock · NASDAQ · Health Care
$59as of 10/16/2026
Price chart
Active signals
ESTA Signal Track Record
How signals performed across all stocks →What ESTA's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 37 | -1.4% | 46% | August 5, 2026 |
| 200-Day Moving Average TouchActive now | 22 | -1.0% | 45% | August 21, 2026 |
| Bollinger Band Breakout | 21 | +1.4% | 52% | July 21, 2026 |
| Bollinger Band Breakdown | 18 | -3.3% | 39% | September 24, 2026 |
| Any 20-session window (baseline) | +1.5% | 53% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ESTA
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospi…
- Sector
- Health Care
- Industry
- Industrial Specialties
- Employees
- 1,004
- Website
- establishmentlabs.com
Fundamentals
- 1-day range
- $59.43$62.41
- Market cap
- $2.33B
- P/E (trailing)
- —
- P/E (forward)
- 1008.42
- EPS (trailing)
- $-1.30
- Dividend yield
- —
- Beta
- 1.00
- Avg. volume
- 427.2K
How Establishment Labs Holdings Inc. Common Shares Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 27, 2026 · via SEC EDGAR / Finnhub
Forecasts
9 analyst ratings
Establishment Labs Holdings Inc. Common Shares Competitors
Chosen by industry and closest market cap.
- ESTAEstablishment Labs Holdings Inc. Common Shares$59.18▼ 3.55%Market cap $2.33BP/E —$38.55$97.59
- ENOVEnovis Corporation Common Stock$19.59▲ 1.24%Market cap $1.51BP/E —$16.7$34.28
- CDRECadre Holdings Inc. Common Stock$26.38▲ 1.77%Market cap $1.50BP/E 30.60$24.07$48.76
- WLFCWillis Lease Finance Corporation Common Stock$37.61▼ 2.18%Market cap $1.35BP/E 10.50$37.59$81.54
- XPELXPEL Inc. Common Stock$43.81▼ 1.11%Market cap $1.31BP/E 22.87$31.88$55.91
- ADSEADS-TEC ENERGY PLC Ordinary Shares$9.93▼ 0.70%Market cap $879.02MP/E —$9.05$13.5
- AVRAnteris Technologies Global Corp. Common Stock$6.05▼ 4.87%Market cap $813.78MP/E —$3.3$11.06
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings Inc. Common Shares | $2.33B | — | $59.18 | ▼ 3.55% | $38.55$97.59 |
| ENOV Enovis Corporation Common Stock | $1.51B | — | $19.59 | ▲ 1.24% | $16.7$34.28 |
| CDRE Cadre Holdings Inc. Common Stock | $1.50B | 30.60 | $26.38 | ▲ 1.77% | $24.07$48.76 |
| WLFC Willis Lease Finance Corporation Common Stock | $1.35B | 10.50 | $37.61 | ▼ 2.18% | $37.59$81.54 |
| XPEL XPEL Inc. Common Stock | $1.31B | 22.87 | $43.81 | ▼ 1.11% | $31.88$55.91 |
| ADSE ADS-TEC ENERGY PLC Ordinary Shares | $879.02M | — | $9.93 | ▼ 0.70% | $9.05$13.5 |
| AVR Anteris Technologies Global Corp. Common Stock | $813.78M | — | $6.05 | ▼ 4.87% | $3.3$11.06 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- TD Cowen Reiterates Buy on Establishment Labs Hldgs, Maintains $117 Price Targetbenzinga · 10/15/2026
- Is Establishment Labs’ (ESTA) Profitability Inflection the Ultimate Buying Opportunity?Yahoo · 9/23/2026
- Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic ImplantsYahoo · 9/21/2026
Insider Activity
Insider Actions →- Custin Ann · September 30, 2026 · Grant301 @ $64.17
- Leslie Gillin · September 30, 2026 · Grant262 @ $64.17
- Slotkin Bryan · September 30, 2026 · Grant253 @ $64.17
- LEWIN NICHOLAS SHERIDAN · September 30, 2026 · Grant389 @ $64.17
- SCHUTTER EDWARD J · September 30, 2026 · Grant253 @ $64.17
- Caldini Filippo · August 20, 2026 · Tax Withholding682 @ $71.52
- Custin Ann · June 30, 2026 · Grant239 @ $85.81
- Leslie Gillin · June 30, 2026 · Grant196 @ $85.81
- Slotkin Bryan · June 30, 2026 · Grant189 @ $85.81
- LEWIN NICHOLAS SHERIDAN · June 30, 2026 · Grant291 @ $85.81
- SCHUTTER EDWARD J · June 30, 2026 · Grant216 @ $85.81
- Harris Taylor C. · June 24, 2026 · Grant1.8K
- Harris Taylor C. · June 24, 2026 · Grant1.9K
- JW Partners, LP · May 28, 2026 · Sale65.1K @ $72.89
- JW Partners, LP · May 27, 2026 · Sale113 @ $72.5
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
ESTA Receives FDA Approval for New Motiva Implant Sizes
Establishment Labs Holdings received FDA clearance for additional sizes of its Motiva implants, expanding its product lineup. The company also reported its Q2 2026 financial results. This regulatory approval is a key development for the medical device maker, potentially broadening its market reach.
ESTA Receives FDA Approval for New Motiva Implant Sizes. Establishment Labs Holdings received FDA clearance for additional sizes of its Motiva implants, expanding its product lineup. The company also reported its Q2 2026 financial results. This regulatory approval is a key development for the medical device maker, potentially broadening its market reach.